Phase II Randomized Trial of mFOLFIRINOX +/- Ramucirumab in Advanced Pancreatic Cancer
Clinical trial NCT02581215 · COMPLETED
Trial details
- NCT number
- NCT02581215
- Sponsor
- Walid Shaib, MD
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-09-11
- Primary completion
- 2021-08-05
- Enrollment
- 84
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.